The MVIS® US Listed Biotech 25 Index (MVBBH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the biotech industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from biotech related products and services, such as research and development, production, or marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Full MCap of at least 150 mln USD. Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews. At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews.
Companies have to generate at least 50% revenues from biotechnology.
Company weightings are capped at 20%.
Semi-annually with quarterly rebalances.
2,421.18 - 5,167.78
3,364.26 - 7,304.38
2,490.21 - 5,380.35
MVIS® US Listed Biotech 25 Price Index
MVIS® US Listed Biotech 25 Total Return Gross Index
MVIS® US Listed Biotech 25 Total Return Net Index
NEWS & RESEARCH
Gain access to all Index Data and receive updates on market developments, index news and corporate announcements.